Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Xia Wen; Jun-Sheng Wang; Janne T. Backman; Jouko Laitila; Pertti J. Neuvonen

doi:10.1124/dmd.30.6.631

Research ArticleArticle

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen

Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

Xia Wen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jun-Sheng Wang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Janne T. Backman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jouko Laitila

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pertti J. Neuvonen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Drug Metabolism and Disposition

Vol. 30, Issue 6

1 Jun 2002

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Message Subject (Your Name) has forwarded a page to you from Drug Metabolism & Disposition

Message Body (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen

Drug Metabolism and Disposition June 1, 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen

Drug Metabolism and Disposition June 1, 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Plain text

Vertical Tabs

Jump to comment:

In this issue

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Citation Manager Formats

Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals